The total sale represents 7.3% of the issued share capital of Haleon, which was created by the merger of GSK and Pfizer's ...

Haleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US ...

Pfizer will sell its remaining stake in British consumer healthcare group Haleon , the companies said on Tuesday.

Pfizer Inc. (PFE) agreed to sell its remaining stake worth $3.3 billion in Haleon PLC (HLN), marking its exit from the UK-based consumer ...

Bengaluru: Pfizer will divest its remaining stake in Haleon, marking its complete exit from the British consumer healthcare ...

GlaxoSmithKline was formerly called GlaxoWelcome before its merger with U.S. pharmaceutical company SmithKline Beecham in 2000. The combination has made GlaxoSmithKline the 6th largest ...

Haleon, known for brands such as Sensodyne, Panadol, and Advil, was created through the merger of GSK and Pfizer’s consumer healthcare businesses in 2019 and spun off as a standalone entity in 2022.

Pfizer sold its entire 7.3% shareholding in London-listed consumer-health company Haleon for a net sum of 2.5 billion pounds ($3.25 billion). Pfizer sold 618 million shares for 385 pence each. The ...

Newspapers have jumped on this by suggesting that GSK is stalking American Home Products, a previous SmithKline merger target and a company with a strong drug pipeline. But chief executive officer ...

Bengaluru] Drugmaker Pfizer has sold its entire stake in Haleon for about US$3.24 billion to institutional investors and the ...